ICDを装着した一次予防患者の評価 - ATPの系統的評価

基本情報

NCT ID

NCT02923726

ステータス

完了

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

2,692

治験依頼者名

Boston Scientific Corporation

概要

The primary objective is to understand the role of antitachycardia pacing (ATP) in primary prevention patients indicated for implantable cardioverter-defibrillator (ICD) therapy and programmed according to current guidance of higher rate cut-offs and therapy delays. The time to first all-cause shock will be tested in subjects with standard therapy (ATP and shocks) compared to subjects programmed to shock only to assess equivalency.

対象疾患

介入

依頼者（Sponsor）

実施施設 (9)